Skip to main navigation

Heartflow One
Why CCTA
- CCTA Advantage
- Clinical Evidence
For Patients
About
- About Us
- Newsroom
- Careers
- Contact
Insights
Investors
Login
language
- United States
- Japan

Heartflow One
Why CCTA
- CCTA Advantage
- Clinical Evidence
For Patients
About
- About Us
- Newsroom
- Careers
- Contact
Insights
Investors
Login
language
- United States
- Japan

Investor Relations

Overview
News & Events
Stock Information
- Stock Information
- Historical Price Lookup
- Stock Information
- Historical Price Lookup
Corporate Governance
Financial Information
IR Resources

Overview
News & Events
Stock Information
- Stock Information
- Historical Price Lookup
Corporate Governance
Financial Information
IR Resources

SEC Filing Details

Document Details

Form

CORRESP

Filing Date

Aug 6, 2025

Document Date

Aug 6, 2025

Form Description

CORRESP

Filing Group

Other

Company

Heartflow, Inc.

Issuer

HEARTFLOW, INC.

Filing Formats

View HTML

Investor Contact

Nick Laudico
Vice President, Investor Relations
nlaudico@heartflow.com

Subscribe to our email alerts

Heartflow One

Platform Overview
Roadmap Analysis
FFR<sub>CT</sub> Analysis
Plaque Analysis
Support

Why CCTA

CCTA Advantage
Clinical Evidence

For Patients

Patient Stories
Understanding CAD
Why Heartflow

About

About Us
Newsroom
Careers
Contact

Insights

Investors

Login

Lang

United States
Japan

Twitter
LinkedIn
Youtube
Heartflow App

Indications
Privacy Policy
Terms of Use
Modern Slavery Statement
Carbon Reduction Plan
Accessibility
Sitemap

The Heartflow Analysis, including FFR_CTAnalysis, Roadmap Analysis, Plaque Analysis, and the PCI Navigator tool, is commercially available in the United States and Europe (EU and UK). Specific functionalities are also available in Japan, Canada, and other select regions. The information provided by Heartflow Analysis is intended to be used in conjunction with the patient’s clinical history, symptoms, and other diagnostic data, as well as the clinician’s professional judgement. The Heartflow Analysis may not be appropriate for all patients. Please consult the Indications for Use and safety information for additional details.

© 2026 Heartflow, Inc. | Heartflow is a registered trademark of Heartflow, Inc. The Heartflow logo, Roadmap, PCI Navigator, Heartflow One, and Heartflow Plaque Staging are claimed trademarks of Heartflow, Inc. | www.heartflow.com | 135 Main St, San Francisco, CA 94105